Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000008:Abdominal Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D000085:Acetates / Q000627:therapeutic use; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D000309:Adrenal Insufficiency / Q000150:complications / Q000188:drug therapy / Q000652:urine; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D002648:Child; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use; D003632:Dichlorodiphenyldichloroethane / Q000627:therapeutic use*; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000652:urine; D008660:Metabolism / Q000187:drug effects; D009362:Neoplasm Metastasis; D011239:Prednisolone / Q000627:therapeutic use; D011859:Radiography; D013156:Splenectomy; D014770:Virilism / Q000209:etiology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000085:Acetates; D005461:Fluorine; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D003632:Dichlorodiphenyldichloroethane; D003348:Cortisone; D006854:Hydrocortisone